Search research articles
Contact Us
Filters
Showing results (241-250 of 349) with videos related to
Page
of 35
Sort By:
Clinical Cardiology
|
November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
Stuart J Pocock, David Brieger, John Gregson, et al.
European Heart Journal
|
July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
Paul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Diabetes Research and Clinical Practice
|
March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study
Marilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Journal of Cardiology
|
December 3, 2021
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry
Juan J Russo, Andrew T Yan, Stuart J Pocock, et al.
European Heart Journal
|
January 18, 2021
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
Milton Packer, Stefan D Anker, Javed Butler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 18, 2023
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled
Subodh Verma, Nitish K Dhingra, Marc P Bonaca, et al.
European Journal of Heart Failure
|
July 14, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program
Milton Packer, Javed Butler, João Pedro Ferreira, et al.
The New England Journal of Medicine
|
May 8, 2009
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
Gregg W Stone, Alexandra J Lansky, Stuart J Pocock, et al.
The New England Journal of Medicine
|
February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Page
of 35
Search research articles
Search
Showing results (241-250 of 349) with videos related to
Sort By:
Page
of 35
Clinical Cardiology
|
November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
Stuart J Pocock, David Brieger, John Gregson, et al.
European Heart Journal
|
July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
Paul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Diabetes Research and Clinical Practice
|
March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study
Marilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Journal of Cardiology
|
December 3, 2021
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry
Juan J Russo, Andrew T Yan, Stuart J Pocock, et al.
European Heart Journal
|
January 18, 2021
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
Milton Packer, Stefan D Anker, Javed Butler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 18, 2023
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled
Subodh Verma, Nitish K Dhingra, Marc P Bonaca, et al.
European Journal of Heart Failure
|
July 14, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program
Milton Packer, Javed Butler, João Pedro Ferreira, et al.
The New England Journal of Medicine
|
May 8, 2009
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
Gregg W Stone, Alexandra J Lansky, Stuart J Pocock, et al.
The New England Journal of Medicine
|
February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Page
of 35